Nuclear medicine in the management of patients with heart failure: Guidance from an expert panel of the International Atomic Energy Agency (IAEA)

Amalia Peix, Claudio Tinoco Mesquita, Diana Paez, Carlos Cunha Pereira, Renata Felix, Claudia Gutierrez, Rodrigo Jaimovich, Barbara Maria Ianni, Jose Soares, Pastor Olaya, Ma Victoria Rodriguez, Albert Flotats, Raffaele Giubbini, Mark I. Travin, Ernest V. Garcia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.

Original languageEnglish (US)
Pages (from-to)818-823
Number of pages6
JournalNuclear Medicine Communications
Volume35
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Nuclear Energy
Nuclear Medicine
Heart Failure
Adrenergic Agents
Perfusion
Myocardial Perfusion Imaging
Ventricular Function
Single-Photon Emission-Computed Tomography
Cardiology
Cardiomyopathies
Radionuclide Imaging
Health Care Costs
Mortality

Keywords

  • coronary artery disease
  • dilated cardiomyopathy
  • gated myocardial perfusion SPECT
  • heart failure
  • left ventricular dyssynchrony
  • MIBG
  • PET imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Nuclear medicine in the management of patients with heart failure : Guidance from an expert panel of the International Atomic Energy Agency (IAEA). / Peix, Amalia; Mesquita, Claudio Tinoco; Paez, Diana; Pereira, Carlos Cunha; Felix, Renata; Gutierrez, Claudia; Jaimovich, Rodrigo; Ianni, Barbara Maria; Soares, Jose; Olaya, Pastor; Rodriguez, Ma Victoria; Flotats, Albert; Giubbini, Raffaele; Travin, Mark I.; Garcia, Ernest V.

In: Nuclear Medicine Communications, Vol. 35, No. 8, 2014, p. 818-823.

Research output: Contribution to journalArticle

Peix, A, Mesquita, CT, Paez, D, Pereira, CC, Felix, R, Gutierrez, C, Jaimovich, R, Ianni, BM, Soares, J, Olaya, P, Rodriguez, MV, Flotats, A, Giubbini, R, Travin, MI & Garcia, EV 2014, 'Nuclear medicine in the management of patients with heart failure: Guidance from an expert panel of the International Atomic Energy Agency (IAEA)', Nuclear Medicine Communications, vol. 35, no. 8, pp. 818-823. https://doi.org/10.1097/MNM.0000000000000143
Peix, Amalia ; Mesquita, Claudio Tinoco ; Paez, Diana ; Pereira, Carlos Cunha ; Felix, Renata ; Gutierrez, Claudia ; Jaimovich, Rodrigo ; Ianni, Barbara Maria ; Soares, Jose ; Olaya, Pastor ; Rodriguez, Ma Victoria ; Flotats, Albert ; Giubbini, Raffaele ; Travin, Mark I. ; Garcia, Ernest V. / Nuclear medicine in the management of patients with heart failure : Guidance from an expert panel of the International Atomic Energy Agency (IAEA). In: Nuclear Medicine Communications. 2014 ; Vol. 35, No. 8. pp. 818-823.
@article{6746af5392dd4fa2a107c4606215503a,
title = "Nuclear medicine in the management of patients with heart failure: Guidance from an expert panel of the International Atomic Energy Agency (IAEA)",
abstract = "Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.",
keywords = "coronary artery disease, dilated cardiomyopathy, gated myocardial perfusion SPECT, heart failure, left ventricular dyssynchrony, MIBG, PET imaging",
author = "Amalia Peix and Mesquita, {Claudio Tinoco} and Diana Paez and Pereira, {Carlos Cunha} and Renata Felix and Claudia Gutierrez and Rodrigo Jaimovich and Ianni, {Barbara Maria} and Jose Soares and Pastor Olaya and Rodriguez, {Ma Victoria} and Albert Flotats and Raffaele Giubbini and Travin, {Mark I.} and Garcia, {Ernest V.}",
year = "2014",
doi = "10.1097/MNM.0000000000000143",
language = "English (US)",
volume = "35",
pages = "818--823",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Nuclear medicine in the management of patients with heart failure

T2 - Guidance from an expert panel of the International Atomic Energy Agency (IAEA)

AU - Peix, Amalia

AU - Mesquita, Claudio Tinoco

AU - Paez, Diana

AU - Pereira, Carlos Cunha

AU - Felix, Renata

AU - Gutierrez, Claudia

AU - Jaimovich, Rodrigo

AU - Ianni, Barbara Maria

AU - Soares, Jose

AU - Olaya, Pastor

AU - Rodriguez, Ma Victoria

AU - Flotats, Albert

AU - Giubbini, Raffaele

AU - Travin, Mark I.

AU - Garcia, Ernest V.

PY - 2014

Y1 - 2014

N2 - Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.

AB - Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.

KW - coronary artery disease

KW - dilated cardiomyopathy

KW - gated myocardial perfusion SPECT

KW - heart failure

KW - left ventricular dyssynchrony

KW - MIBG

KW - PET imaging

UR - http://www.scopus.com/inward/record.url?scp=84903791289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903791289&partnerID=8YFLogxK

U2 - 10.1097/MNM.0000000000000143

DO - 10.1097/MNM.0000000000000143

M3 - Article

C2 - 24781009

AN - SCOPUS:84903791289

VL - 35

SP - 818

EP - 823

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 8

ER -